Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 15, 2017
Reporting Period: The filing announces financial results for the quarter and fiscal year ended December 31, 2016.
Key Financial Metrics
The provided text is a cover report referencing a press release (Exhibit 99.1) containing the actual financial data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release for this information.
Guidance, Outlook, and Risks
The filing references a press release titled "Capricor Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update." While the title indicates a corporate update was provided, the specific guidance, outlook, management commentary, risks, contingencies, or unusual items are not detailed in the text of this Form 8-K.
Important Facts for Investor Verification
- Verify the specific financial results for Q4 and Full Year 2016 in the attached Exhibit 99.1 press release, as they are not listed in the main body of this filing.
- Note that the information furnished under Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section unless expressly incorporated by reference.
- Confirm the company's cash position and burn rate from the full press release to assess liquidity runway, as this 8-K does not state these figures.